Stefan Oelrich

Stability in Motion

Amid global uncertainty, Bayer Pharma, led by Stefan Oelrich, pursues strategic transformation to boost resilience, drive innovation, and secure sustainable growth in a changing healthcare landscape.

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Interconnected Global Chemicals Logistics

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Bayer AG

Stefan Oelrich

Stability in Motion

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Upcoming Virtual Events

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Interview

Driving Transformation

Stefan Oelrich

Stability in Motion

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Upcoming Virtual Events

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Interview

Driving Transformation

Newsletter & e-edition